Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for stem cells and stromal vascular fraction treatment in temporomandibular joint disorders, currently in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem Cells and Stromal Vascular Fraction therapy

Snippet

Sponsor: TC Erciyes University | Conditions: Temporomandibular Joint Disorders, Temporomandibular Disorder | Phase 1, Phase 2 | Status: UNKNOWN